This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Robert de Jong
Associate Director Antibody Research & Technology at Genmab


Dr. Rob de Jong has worked in different roles at Genmab since 2007, spanning a.o. molecular biology, CMC-supportive research, and protein engineering and is an inventor of Genmab’s HexaBody® and HexElect® technologies. He currently leads Genmab’s Antibody Format Development efforts, aimed at translating biomolecular and structural insights into novel therapeutic antibody platform technologies.

Agenda Sessions

  • Therapeutic IgG Antibody Combinations Acting as Bio-Logic AND Gates